Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.

Kendra Hutchinson, Patricia M. Kopko, Kathryn N. Muto, Joseph Tuscano, Robert T O'Donnell, Paul V. Holland, Carol M Richman, Teresa G. Paglieroni, Theodore Wun

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

BACKGROUND: Transfusion-associated GVHD (TA-GVHD) is an uncommon complication of blood transfusion. Diagnosis of TA-GVHD is difficult, and it is usually rapidly fatal. There are few documented sur- vivors of TA-GVHD. CASE REPORT: A 61-year-old woman with chronic lymphocytic leukemia (CLL) was treated with fludarabine followed by combination chemotherapy and high-dose radioimmunotherapy and peripheral blood progenitor cell (PBPC) rescue. She was transfused with nonirradiated blood components at an outside hospital and presented 10 days later with rash, elevated liver enzymes, and progressive pancytopenia. Skin biopsy was consistent with GVHD, and HLA typing of lymphocytes from the patient demonstrated mixed chimerism. The patient was treated with solumedrol and cyclosporin A, followed by high-dose cyclophosphamide and antithymocyte globulin and autologous PBPC infusion. She had rapid engraftment, resolution of skin rash, and normalization of liver function abnormalities. She is in good health with normal blood counts and no evidence of CLL 34 months after transplantation. CONCLUSION: TA-GVHD occurs in the setting of an immunocompromised recipient receiving nonirradiated blood components. A typical presentation includes skin rash, liver function abnormalities, and pancytopenia. Demonstration of mixed chimerism by HLA typing facilitated diagnosis in this patient. High-dose immunosuppression, facilitated by the availability of autologous PBPCs, resulted in a successful outcome.

Original languageEnglish (US)
Pages (from-to)1567-1572
Number of pages6
JournalTransfusion
Volume42
Issue number12
StatePublished - Dec 2002

Fingerprint

Cell Transplantation
Exanthema
Early Diagnosis
Histocompatibility Testing
Blood Cells
Pancytopenia
Chimerism
Stem Cells
B-Cell Chronic Lymphocytic Leukemia
Liver
Methylprednisolone Hemisuccinate
Radioimmunotherapy
Antilymphocyte Serum
Combination Drug Therapy
Blood Transfusion
Cyclophosphamide
Immunosuppression
Cyclosporine
Survivors
Therapeutics

ASJC Scopus subject areas

  • Hematology
  • Immunology

Cite this

Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation. / Hutchinson, Kendra; Kopko, Patricia M.; Muto, Kathryn N.; Tuscano, Joseph; O'Donnell, Robert T; Holland, Paul V.; Richman, Carol M; Paglieroni, Teresa G.; Wun, Theodore.

In: Transfusion, Vol. 42, No. 12, 12.2002, p. 1567-1572.

Research output: Contribution to journalArticle

@article{d16b822eac3f414da5b9e8e47a6530dc,
title = "Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.",
abstract = "BACKGROUND: Transfusion-associated GVHD (TA-GVHD) is an uncommon complication of blood transfusion. Diagnosis of TA-GVHD is difficult, and it is usually rapidly fatal. There are few documented sur- vivors of TA-GVHD. CASE REPORT: A 61-year-old woman with chronic lymphocytic leukemia (CLL) was treated with fludarabine followed by combination chemotherapy and high-dose radioimmunotherapy and peripheral blood progenitor cell (PBPC) rescue. She was transfused with nonirradiated blood components at an outside hospital and presented 10 days later with rash, elevated liver enzymes, and progressive pancytopenia. Skin biopsy was consistent with GVHD, and HLA typing of lymphocytes from the patient demonstrated mixed chimerism. The patient was treated with solumedrol and cyclosporin A, followed by high-dose cyclophosphamide and antithymocyte globulin and autologous PBPC infusion. She had rapid engraftment, resolution of skin rash, and normalization of liver function abnormalities. She is in good health with normal blood counts and no evidence of CLL 34 months after transplantation. CONCLUSION: TA-GVHD occurs in the setting of an immunocompromised recipient receiving nonirradiated blood components. A typical presentation includes skin rash, liver function abnormalities, and pancytopenia. Demonstration of mixed chimerism by HLA typing facilitated diagnosis in this patient. High-dose immunosuppression, facilitated by the availability of autologous PBPCs, resulted in a successful outcome.",
author = "Kendra Hutchinson and Kopko, {Patricia M.} and Muto, {Kathryn N.} and Joseph Tuscano and O'Donnell, {Robert T} and Holland, {Paul V.} and Richman, {Carol M} and Paglieroni, {Teresa G.} and Theodore Wun",
year = "2002",
month = "12",
language = "English (US)",
volume = "42",
pages = "1567--1572",
journal = "Transfusion",
issn = "0041-1132",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Early diagnosis and successful treatment of a patient with transfusion-associated GVHD with autologous peripheral blood progenitor cell transplantation.

AU - Hutchinson, Kendra

AU - Kopko, Patricia M.

AU - Muto, Kathryn N.

AU - Tuscano, Joseph

AU - O'Donnell, Robert T

AU - Holland, Paul V.

AU - Richman, Carol M

AU - Paglieroni, Teresa G.

AU - Wun, Theodore

PY - 2002/12

Y1 - 2002/12

N2 - BACKGROUND: Transfusion-associated GVHD (TA-GVHD) is an uncommon complication of blood transfusion. Diagnosis of TA-GVHD is difficult, and it is usually rapidly fatal. There are few documented sur- vivors of TA-GVHD. CASE REPORT: A 61-year-old woman with chronic lymphocytic leukemia (CLL) was treated with fludarabine followed by combination chemotherapy and high-dose radioimmunotherapy and peripheral blood progenitor cell (PBPC) rescue. She was transfused with nonirradiated blood components at an outside hospital and presented 10 days later with rash, elevated liver enzymes, and progressive pancytopenia. Skin biopsy was consistent with GVHD, and HLA typing of lymphocytes from the patient demonstrated mixed chimerism. The patient was treated with solumedrol and cyclosporin A, followed by high-dose cyclophosphamide and antithymocyte globulin and autologous PBPC infusion. She had rapid engraftment, resolution of skin rash, and normalization of liver function abnormalities. She is in good health with normal blood counts and no evidence of CLL 34 months after transplantation. CONCLUSION: TA-GVHD occurs in the setting of an immunocompromised recipient receiving nonirradiated blood components. A typical presentation includes skin rash, liver function abnormalities, and pancytopenia. Demonstration of mixed chimerism by HLA typing facilitated diagnosis in this patient. High-dose immunosuppression, facilitated by the availability of autologous PBPCs, resulted in a successful outcome.

AB - BACKGROUND: Transfusion-associated GVHD (TA-GVHD) is an uncommon complication of blood transfusion. Diagnosis of TA-GVHD is difficult, and it is usually rapidly fatal. There are few documented sur- vivors of TA-GVHD. CASE REPORT: A 61-year-old woman with chronic lymphocytic leukemia (CLL) was treated with fludarabine followed by combination chemotherapy and high-dose radioimmunotherapy and peripheral blood progenitor cell (PBPC) rescue. She was transfused with nonirradiated blood components at an outside hospital and presented 10 days later with rash, elevated liver enzymes, and progressive pancytopenia. Skin biopsy was consistent with GVHD, and HLA typing of lymphocytes from the patient demonstrated mixed chimerism. The patient was treated with solumedrol and cyclosporin A, followed by high-dose cyclophosphamide and antithymocyte globulin and autologous PBPC infusion. She had rapid engraftment, resolution of skin rash, and normalization of liver function abnormalities. She is in good health with normal blood counts and no evidence of CLL 34 months after transplantation. CONCLUSION: TA-GVHD occurs in the setting of an immunocompromised recipient receiving nonirradiated blood components. A typical presentation includes skin rash, liver function abnormalities, and pancytopenia. Demonstration of mixed chimerism by HLA typing facilitated diagnosis in this patient. High-dose immunosuppression, facilitated by the availability of autologous PBPCs, resulted in a successful outcome.

UR - http://www.scopus.com/inward/record.url?scp=0036887284&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0036887284&partnerID=8YFLogxK

M3 - Article

C2 - 12473136

AN - SCOPUS:0036887284

VL - 42

SP - 1567

EP - 1572

JO - Transfusion

JF - Transfusion

SN - 0041-1132

IS - 12

ER -